Showing results (301-310 of 575) with videos related to

Sort By:
Pageof 58
BMJ Open|June 22, 2026
Narrative exposure therapy in early intervention in psychosis services (NETp): protocol of a multi-site feasibility randomised controlled trial studyMiriam Fornells-Ambrojo, James Plaistow, Amy Hardy, et al.
Archivos Espanoles De Urologia|October 17, 2002
[Testosterone substitution in patients with hypogonadism]Francisco José Martínez Portillo, Armando Cueva Martínez, Peter Martin Braun, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 3, 2025
The prognostic impact of lymph node yield in deficient and proficient mismatch repair colon cancers: A retrospective national cohort studyFrederik W Bækgaard, Anisoara Iordache, Andreas Hurup Nordholm, et al.
Scientific Reports|May 14, 2026
Tumour location and mismatch repair status impact gene expression profiles associated with lymph node metastases in T1 colon cancersAnders L Ebbehøj, Lars N Jørgensen, Deepthi Chiranth, et al.
Leukemia & Lymphoma|January 24, 2012
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphomaRebecca L Elstrom, Biree Andemariam, Peter Martin, et al.
JMIR Mhealth and Uhealth|October 16, 2019
Metadata Correction: A Mobile Health Wallet for Pregnancy-Related Health Care in Madagascar: Mixed-Methods Study on Opportunities and ChallengesNadine Muller, Peter Martin Ferdinand Emmrich, Elsa Niritiana Rajemison, et al.
European Journal of Cancer Care|April 24, 2015
Insights into hospitalisation of advanced cancer patients: a study of medical recordsAdam Bostanci, Dell Horey, Kate Jackson, et al.
Cancer|March 15, 2008
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapyMorton Coleman, Peter Martin, Jia Ruan, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Improvements in Outcomes in Older Patients With Mantle Cell Lymphoma Are Associated With Improvements Across Multiple Lines of TherapyDanny Luan, Neela Easwar, Zhengming Chen, et al.
Cancer|September 6, 2013
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare StudyPeter Martin, Michelle Byrtek, Keith Dawson, et al.
Pageof 58